Search by Drug Name or NDC

NDC 53002-1252-03 Triamterene and Hydrochlorothiazide 25; 37.5 mg/1; mg/1 Details

Triamterene and Hydrochlorothiazide 25; 37.5 mg/1; mg/1

Triamterene and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is HYDROCHLOROTHIAZIDE; TRIAMTERENE.

MedlinePlus Drug Summary

The combination of triamterene and hydrochlorothiazide is used to treat high blood pressure and edema (fluid retention; excess fluid held in body tissues) in patients who have lower amounts of potassium in their bodies or for whom low potassium levels in the body could be dangerous. The combination of triamterene and hydrochlorothiazide is in a class of medications called diuretics ('water pills'). They work by causing the kidneys to get rid of unneeded water and salt from the body into the urine. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.

Related Packages: 53002-1252-03
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Triamterene and Hydrochlorothiazide

Product Information

NDC	53002-1252
Product ID	53002-1252_f789510c-5cb6-47b4-9ab4-20a7d2bc944c
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Triamterene and Hydrochlorothiazide
Proprietary Name Suffix	n/a
Non-Proprietary Name	Triamterene and Hydrochlorothiazide
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	25; 37.5
Active Ingredient Units	mg/1; mg/1
Substance Name	HYDROCHLOROTHIAZIDE; TRIAMTERENE
Labeler Name	RPK Pharmaceuticals, Inc.
Pharmaceutical Class	Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA073449
Listing Certified Through	2024-12-31

Package

NDC 53002-1252-03 (53002125203)

Pricing Information	N/A
NDC Package Code	53002-1252-3
Billing NDC	53002125203
Package	30 TABLET in 1 BOTTLE (53002-1252-3)
Marketing Start Date	2017-09-01
NDC Exclude Flag	N